Vaccines Market Research Reports & Industry Analysis
Because of the large number of deadly diseases that have been eliminated through the proliferation of effective vaccines, vaccination is generally viewed as one of the greatest public health achievements of the 20th century. Key issues in the global vaccine market today include unequal access to vaccines, supply chain disruptions, the use of vaccines to prevent pandemics and address bioterrorism, technological innovations, and vaccine hesitancy. Learn more about this critical field with the comprehensive selection of vaccine market research reports available on MarketResearch.com.
New Vaccines Market Data and Insights
- Find data on vaccine market size segmented by region, technology, distribution channel, type, route of administration, and disease.
- Gain a deep understanding of vaccine industry dynamics, market structure, growth outlook, and competitive landscape.
- Learn about influential government initiatives and new vaccination technologies that have highly promising results.
Your Source for Expert Data and Analysis
MarketResearch.com is a trusted research partner, backed by over two decades of experience. Our clients include top investment banks, management consulting firms, and leading multinational companies within the Fortune 500. Our team of research specialists is dedicated to guiding you at every step, ensuring you have the resources and insights you need to answer your toughest research questions. Browse our full list of vaccines industry reports today.
Vaccines Industry Research & Market Reports
-
Microneedle Drug Delivery Systems Market Size, Trends, Analysis, and Outlook By Type (Solid, Hollow, Dissolving, Coated, Others), By Material (Silicon, Metal, Polymer, Others), By Application (Dermatology, Drug delivery, Pain management, Cancer therapy, Vaccine delivery, Others), by Region, Country, Segment, and Companies, 2024-2030
... by Region, Country, Segment, and Companies, 2024-2030 The global Microneedle Drug Delivery Systems market size is poised to register 8.03% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. ... Read More
-
Neglected Tropical Disease Treatment Market Size, Trends, Analysis, and Outlook By Disease (Dengue, Rabies, Trachoma, Buruli ulcer, Yaws, Leprosy, Chagas disease, Human African trypanosomiasis, Leishmaniases, Soil-transmitted helminthiases, Others), By Product (Drugs, Vaccines), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Neglected Tropical Disease Treatment market size is poised to register 4.94% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Microbial Fermentation Technology Market Size, Trends, Analysis, and Outlook By Application (Antibiotics, Probiotics Supplements, Monoclonal Antibodies, Recombinant Proteins, Biosimilars, Vaccines, Enzymes, Small Molecules, Others), By End-user (Bio-Pharmaceutical Companies, Contract Research Organizations (CROs), CMOs & CDMOs, Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030 The global Microbial Fermentation Technology market size is poised to register 6.62% growth from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
Fetal Bovine Serum Market Size, Trends, Analysis, and Outlook By Product (Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, Stem Cell, Others), By Application (Biopharmaceuticals, Cell Culture Media, Human and Animal Vaccine Production, Others), By End-User (Research and Academic Institutes, Biotechnology and Pharmaceutical Industry, Others), by Region, Country, Segment, and Companies, 2024-2030
... By End-User (Research and Academic Institutes, Biotechnology and Pharmaceutical Industry, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Fetal Bovine Serum market size is poised to register 7.41% growth from 2024 to 2030, ... Read More
-
Animal Vaccines Market Size, Trends, Analysis, and Outlook By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines), By Animal Type (Livestock, Poultry, Aqua, Ruminants, Swine, Companion, Canine, Feline, Others), By Route of Administration (Subcutaneous, Intramuscular, Intranasal), by Region, Country, Segment, and Companies, 2024-2030
... of Administration (Subcutaneous, Intramuscular, Intranasal), by Region, Country, Segment, and Companies, 2024-2030 The global Animal Vaccines market size is poised to register 6.59% growth from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
Adeno Associated Virus Vector Manufacturing Market Size, Trends, Analysis, and Outlook By Scale of Operations (Clinical, Preclinical, Commercial), By Therapeutic Area (Hematological Diseases, Infectious Diseases, Genetic Disorders, Neurological Disorders, Ophthalmic Disorders, Others), By Application (Cell Therapy, Gene Therapy, Vaccine), By Method (In Vitro, In Vivo), by Region, Country, Segment, and Companies, 2024-2030
... Therapy, Gene Therapy, Vaccine), By Method (In Vitro, In Vivo), by Region, Country, Segment, and Companies, 2024-2030 The global Adeno Associated Virus Vector Manufacturing market size is poised to register 23.77% growth from 2024 to ... Read More
-
Recombinant Proteinrapeutics CDMO Market Size, Trends, Analysis, and Outlook By Type (Growth Hormones, Interferons, Vaccines, Immunostimulating Agents, Others), By Source (Mammalian Systems, Microbial Systems, Others), By Indication (Oncology, Infectious Diseases, Immunological Disorders, Metabolic Disorders, Haematological Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030
... Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Recombinant Proteinrapeutics CDMO market size is poised to register 12.58% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the ... Read More
-
AAV Contract Development and Manufacturing Organizations Market Size, Trends, Analysis, and Outlook By Workflow (Upstream Processing, Downstream Processing), By Type (Adherent Culture, Suspension Culture), By Application (Cell & Gene Therapy Development, Vaccine Development, Biopharmaceutical and Pharmaceutical Discovery, Biomedical Research), By End-user (Pharmaceutical and Biopharmaceutical Companies, Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... Pharmaceutical Discovery, Biomedical Research), By End-user (Pharmaceutical and Biopharmaceutical Companies, Academic & Research Institutes), by Region, Country, Segment, and Companies, 2024-2030 The global AAV Contract Development and Manufacturing Organizations market size is poised to register ... Read More
-
Rabies Veterinary Vaccines Market Size, Trends, Analysis, and Outlook By Application (Companion Animals, Livestock Animals, Wildlife Animals), by Region, Country, Segment, and Companies, 2024-2030
... 4.28% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Rabies Veterinary Vaccines market across By Application (Companion Animals, Livestock Animals, Wildlife Animals). ... Read More
-
mRNA Therapeutics Market Size, Trends, Analysis, and Outlook By Product (Vaccines, Drugs), By Application (Infectious Diseases, Rare Genetic Diseases, Respiratory Diseases, Others), By End-user (Hospitals & Clinics, Research & Others), by Region, Country, Segment, and Companies, 2024-2030
... Companies, 2024-2030 The global mRNA Therapeutics market size is poised to register 2.16% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global mRNA ... Read More
-
Vaccine Delivery Devices Market Size, Trends, Analysis, and Outlook By Device (Syringes, Jet Injectors, Others), By Route of Administration (Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination, Others), by Region, Country, Segment, and Companies, 2024-2030
... Vaccine Delivery Devices market size is poised to register 7.35% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Vaccine Delivery Devices market ... Read More
-
Smart Syringes Market Size, Trends, Analysis, and Outlook By Therapeutics (Auto-disable syringes, Active safety syringes, Passive safety syringes), By Application (Drug delivery, Vaccination, Blood specimen collection), By End-user (Hospitals and HMOs, Diabetic patients, Family practices, Psychiatrists, Others), by Region, Country, Segment, and Companies, 2024-2030
... Psychiatrists, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Smart Syringes market size is poised to register 10.4% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. ... Read More
-
Human Rabies Vaccines Market Size, Trends, Analysis, and Outlook By Cell Line Type (Chick Embryo Cells, Vero Cell, BHK Cells, Others), By Application (Pre Exposure Prophylaxis, Post Prophylaxis), By Route of Administration (Intravenous, Subcutaneous), By End-User (Hospitals, Homecare, Specialty Clinics, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... End-User (Hospitals, Homecare, Specialty Clinics, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Human Rabies Vaccines market size is poised to register 5.02% growth ... Read More
-
mRNA Therapeutics Contract Development and Manufacturing Market Size, Trends, Analysis, and Outlook By Application (Viral Vaccines, Protein Replacement Therapies, Cancer Immunotherapies), By Indication (Infectious Diseases, Metabolic & Genetic Diseases, Cardiovascular & Cerebrovascular Diseases), By End-user (Biotech Companies, Pharmaceutical companies, Government & Academic Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... (Biotech Companies, Pharmaceutical companies, Government & Academic Research Institutes), by Region, Country, Segment, and Companies, 2024-2030 The global mRNA Therapeutics Contract Development and Manufacturing market size is poised to register 11.37% growth from 2024 to ... Read More
-
BCG Vaccine Market Size, Trends, Analysis, and Outlook By Product (Immune BCG, Therapy BCG), By Age Group (Paediatrics, Adults), By Application (Tuberculosis, Bladder Cancer), By Distribution Channel (Hospitals, Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
... Companies, 2024-2030 The global BCG Vaccine market size is poised to register 6.77% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global BCG ... Read More
-
The 2025-2030 World Outlook for Human Papillomavirus Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Human Influenza Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Hepatitis B Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Clostridium Vaccines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Cholera Vaccines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Zika Virus Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Subunit Animal Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Potential Analysis of Human DNA Vaccines
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Human Vaccines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Live Vaccines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
Research Assistance
